SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

They will have to be a reverse split

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
headshrink3 Member Profile
 
Followed By 2
Posts 94
Boards Moderated 0
Alias Born 04/24/13
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/25/2015 3:58:17 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/25/2015 3:52:57 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/25/2015 3:45:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2015 9:22:29 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/11/2015 9:41:49 AM
RXi Pharmaceuticals Announces Closing of the Exclusive Global Licensing Agreement to Samcyprone™ with Hapten Pharmaceutical... "PR Newswire (US)" - 2/5/2015 7:02:00 AM
RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications "PR Newswire (US)" - 2/3/2015 7:02:00 AM
RXi Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference "PR Newswire (US)" - 2/2/2015 7:02:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/27/2015 4:31:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/23/2015 8:51:51 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/20/2015 11:57:33 AM
RXi Pharmaceuticals to Present at the 7th Annual Biotech Showcase™ "PR Newswire (US)" - 1/5/2015 7:02:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/31/2014 8:41:46 AM
RXi Pharmaceuticals Issues Open Letter to Shareholders "PR Newswire (US)" - 12/22/2014 7:02:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/19/2014 4:20:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/19/2014 4:17:18 PM
RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound "PR Newswire (US)" - 12/19/2014 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 12/18/2014 4:36:54 PM
RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of En... "PR Newswire (US)" - 12/17/2014 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2014 7:21:43 AM
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2014 "PR Newswire (US)" - 11/13/2014 7:10:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/13/2014 7:02:18 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/14/2014 9:36:15 AM
RXi Pharmaceuticals to Present New Data in its First Phase 2a Clinical Trial with RXI-109 "PR Newswire (US)" - 10/7/2014 7:02:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 10/3/2014 10:00:53 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist